Media and News

PHARMANOVA’S LICENSEE INITIATES PHASE 3 CLINICAL PROGRAM FOR NON-HORMONAL MENOPAUSAL HOT FLASH TREATMENT
PharmaNova’s licensee, Depomed, Inc., announced today the initiation of the first of two pivot... Read More »

PharmaNova to present at BioPartnering Europe 2008
PharmaNova, Inc. and our affiliate company PharmaNova Europa Ltd. will be presenting and exhibiting ... Read More »

PharmaNova to exhibit at Bio-2008: San Diego Convention Center – June 17-20, 2008.
PharmaNova Inc. will be exhibiting in the NY State Bio Pavilion at the 2008 Bio International Confer... Read More »

Rochester, NY, January 25th. 2008: PharmaNova, Inc. Appoints Deepak Thassu as Vice-President, Pharmaceutical Development.
Press release: Rochester, NY, January 25th. 2008. PharmaNova, Inc. Appoints Deepak Thassu as V... Read More »

PharmaNova to present at UK conference, BioPartnering Europe 2007.
Rochester, New York: August 17, 2007. PharmaNova Inc. announced today that the company&... Read More »

Rochester, NY: PharmaNova partners with diagnostics and device company, Rochester Innovations
PharmaNova Inc. announced today that it has entered into a collaboration with Rochester Innovations ... Read More »

PharmaNova expands into new lab. facilities to accelerate its nanoparticle R&D. See "Contact us" for new address.
... Read More »

PharmaNova forms Strategic Alliance with Taiwan based Orient Europharma
PharmaNova Inc., announced today that it has formed a strategic alliance and collaboration with Orie... Read More »

PHARMANOVA'S LICENSEE DEPOMED FILES INVESTIGATIONAL NEW DRUG APPLICATION FOR GABAPENTIN GR FOR THE TREATMENT OF POSTMENOPAUSAL HOT FLASHES
MENLO PARK, Calif., Mar 12, 2007 (BUSINESS WIRE) -- Depomed, Inc. (NASDAQ:DEPO) announced today that... Read More »

PHARMANOVA GRANTS EXCLUSIVE U.S. LICENSE TO DEPOMED FOR EXTENDED RELEASE GABAPENTIN USE IN HOT FLASHES
Rochester, New York, October 18, 2006 – PharmaNova, Inc. announced today that it has exclusive... Read More »

View Media Archive »

Members of the media wishing to learn more about Pharmanova should contact: Rafael Larramendi, Vice President, Worldwide Business Development. Rafael.Larramendi@pharmanovaco.com, +1-(585)-413-4721.